US2515898A - Procaine penicillin and therapeutic compositions - Google Patents

Procaine penicillin and therapeutic compositions Download PDF

Info

Publication number
US2515898A
US2515898A US774183A US77418347A US2515898A US 2515898 A US2515898 A US 2515898A US 774183 A US774183 A US 774183A US 77418347 A US77418347 A US 77418347A US 2515898 A US2515898 A US 2515898A
Authority
US
United States
Prior art keywords
penicillin
procaine
salt
water
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US774183A
Inventor
Jr Harley W Rhodehamel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25100484&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US2515898(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority to US774183A priority Critical patent/US2515898A/en
Priority to GB3193/48A priority patent/GB651412A/en
Priority to AU18762/48A priority patent/AU141817B2/en
Application granted granted Critical
Publication of US2515898A publication Critical patent/US2515898A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems

Definitions

  • This invention relates to relatively insoluble salts of penicillin, particularly procaine penicillin, to the preparation of such salts, and to compositions embodying them.
  • penicillin has been prepared and used in the form of its simple salts, usually the sodium or potassium salt.
  • Such salts are highly soluble in water and in the body fluids and tend to decompose in their presence.
  • the penicillin When such salts are injected, as in water solution, the penicillin not only tends to decompose, but is rapidly taken up in the body fluids and is soon eliminated in the urine; so that the penicillin concentration in the blood remains at an effective level for but a short period of time. Because of this, when the penicillin is administered in aqueous solution, it has been necessary to give frequent injections, usually every three or four hours.
  • Penicillin therapy requires the maintenance of effective blood concentrations over prolonged periods, usually for several days, and the necessity for frequent iniections is extremely burdensome both to the doctor and to the patient. Many attempts have been made to eliminate thenecessity for these frequent injections and to obtain some means of producing an efiective blood concentration of pencillin over a prolonged period, desirably at least 24 hours; without the necessity for such frequent injections.
  • One method which has been used for this purpose is by injecting the penicillin in suspension in a mixture of oil and beeswax; and while with proper concentrations and especially with suiilcient beeswax, this has been somewhat successful in producing prolonged effective concentrations of penicillin, its use is disagreeable to the patient, it may cause fibrosis, and it leaves a residual mass of beeswax which may not be absorbed by the body for several months and which in some cases requires surgical removal.
  • I provide a salt of penicillin which is relatively insoluble in water and in body fluids and is non-toxic, which can be administered without discomfort to the patient and to leave no residue, and which will readily provide a supply in the body from which the penicillin will slowly absorb to maintain effective concentrations of penicillin in the blood stream over prolonged periods of time.
  • the known salts of penicillin maintenance of effective concentrations of penicillin requires eight or more aqueous injections per day, with my salt effective concentrations may be maintained with but a single aqueous injection a day.
  • procaine forms a salt with penicillin which is relatively insoluble in water 2 and in the body fluids, and that infrequent administrations of this salt, usually not oftener than once each day, will readily maintain effective concentrations of penicillin in the blood over prolonged periods.
  • procaine-penicillin salt not only permits the maintenance of effective blood concentrations of penicillin over prolonged periods, but also provides the procaine for its anesthetic eifect and its anti-allergy effect.
  • the pencillin embodied in the'salt may be a mixture of one or more of the several specific penicillins, as obtained in the usual production of penicillin, or may be a penicillin which consists mainly or wholly of one of these specific penicillins.
  • a penicillin which is rich in penicillin G (benzyl penicillin), in part for the excellent therapeutic qualities of penicillin G but also because I find it especially useful in forming salts with desirable physical properties.
  • the penicillin used may be either an amorphous penicillin or preferably a crystalline penicillin; and in preparing the salt, I start with either a dry penicillin or a purified solution containing the penicillin, and such solution may be One obtained directly, as by extraction, from the broth in which the penicillin is produced.
  • the new procaine penicillin salt may be administered in any desired way.
  • the usually preferred way is by intra-muscular injection of a suspension of the procaine penicillin in water or other aqueous menstruum, i. e. aqueous suspending medium, or in any of the commonly used oily menstruums, i. e. oily suspending media.
  • the suspension is desirably a freshly prepared one, because of thetendency of the penicillin to decompose in the presence of water.
  • the solid procaine penicillin in an amount to provide a unit dosage desirably about 200,000 to 300,000 international penicillin units, is put up in a sealed ampoule in combination with an ampoule of a suitable quantity of aqueous menstruum, so that the doctor may combine the two shortly before administration.
  • the procaine penicillin salt is contained in its ampoule in finely divided state, preferably less than 40' mesh size and most desirably about mesh slze.
  • the amount of aqueous menstruum supplied in the combined vial is desirably small, but is sufficient to form a suspension of a consistency suitable for injection.
  • procaine penicillin With 200,000 to 300,000 units of procaine penicillin having a potency of 1,000 units per mg., I desirably use about 1 ml. of aqueous menstruum.
  • My procaine penicillin salt lends itself to this advantageous method of administration, for it forms crystals which may be sufllciently finely divided to form the suitable suspension, and such finely divided crystalline material lends itself to convenient packaging in ampoules and when so packaged remains stable over long periods and can be distributed by usual methods and through usual channels.
  • my penicillin salt is also of advantage.
  • line material may be suspended in any of the commonly used injectable oily menstruums, and
  • suspension may be distributed through the usual channels in the usual way and will remain stable and available for immediate use .without preliminary mixing.
  • My procaine-penicillin salt may be prepared by simply bringing the procaine and the penicillin together, desirably with the procaine in excess, in solution in a suitable reaction solvent.
  • the procaine penicillin is relatively insoluble both in water and in convenient organic solvents so that it precipitates from the reaction mixture, usually quite promptly as a solid, and is conveniently recovered by filtration.
  • the penicillin is conveniently and desirably added in the form of any of its usual soluble salts, such as the ammonium, potassium, sodium, or calcium salts.
  • the procaine may likewise be present in the form of its soluble salt, such as its hydrohalide, sulfate, nitrate, formate. or the like.
  • the aqueous reaction mixture may be prepared in any convenient way; one of the reactants, conveniently the penicillin, may be provided in solution in sufiicient water for the reaction mixture, and the other reactant added thereto, or preferably, water solutions of each of the reactants are combined.
  • one of the reactants conveniently the penicillin
  • the other reactant added thereto, or preferably, water solutions of each of the reactants are combined.
  • the reaction mixture is desirably allowed to stand in the cold.
  • the procaine penicillin is recovered, as b filtration, and is then preferably washed first with water and then with a low-boiling water miscible solvent, such as acetone, and then dried under vacuum.
  • the penicillin is desirably supplied in acid form, and the The finely divided crystalprocaine desirably in base form.
  • the two reactants and the solvent may be brought together in any desired order.
  • the penicillin, in acid form, and the procaine, in base form are brought together in organic solution, they react to form the desired procaine-penicillin salt, which precipitates.
  • the precipitate is recovered by filtration, and is desirably washed with an additional quantity of organic solvent and dried.
  • the reaction solvent For preparation of the procaine penicillin in organic solution, I preferably use as the reaction solvent an alkyl acetate 01' from about 4 to 9 carbon atoms, and most desirably use amyl acetate.
  • Other solvents such as ether or chloroform, in which the two reactants are soluble and the procaine-penicillin is relatively insoluble, may also be used; but I find that with such other solvents the procaine-penicillin sometimes precipitates as an oil instead of in the more desirable, solid crystalline state, and that sometimes the occurrence of precipitation is delayed.
  • the penicillin In the preparation of procaine penicillin, both in water solution and in organic solvent solution, the penicillin must of course be present in a, concentration greater than the solubility of procaine penicillin in the solvent (about 0.7% in water at 28 C.), and for efllcient recoverythe penicillin should be present in a substantially higher concentration, desirably close to its maximum solubility.
  • the penicillin used should be of fairly high purity, desirably of at least purity, for the co-presence of excessive impurities may interfere with the formation of the procaine penicillin or with its recovery in crystalline form.
  • dry sodium or potassium penicillin G which when pure have potencies of about 1,667 units and 1,595 units per mg. respectively, I have found it suitable to use a penicillin having a potency of about 1200 units per mg., but I prefer to use a penicillin of substantially higher potency.
  • the penicillin is desirably brought to the reaction mixture in solution, and the penicillin-containing solution may be-one which is obtained directly by extractive procedure from the broth in which the penicillin is produced.
  • the penicillin-containing solution may for example be the first organic extract of the broth, or may be the first aqueous extract thereof, derived by extraction of that organic extract, or may be a subsequent extract, either aqueous or organic.
  • the penicillin is obtained in such an extract from the broth, it is desirably decolorized in organic solution before use by any suitable method.
  • the procaine penicillin obtained by the procedures set forth above is usually obtained in the form of crystals, although sometimes, especially when the reaction solvent is other than water or amyl acetate, the procaine penicillin may precipitate as an oil which solidifies on standing.
  • crystalline procaine penicillin in finely divided state, preferably about 40 to about mesh size.
  • the crystal size obained in the preparation of my procaine penicillin may be modified by suitably controlling the conditions under which the reaction is carried out, and crystal size is reduced by carrying out the reaction at reduced temperature and with vigorous stirring.
  • the material if not obtained in a sufficient state of division readily lends itself to further reduction by grinding, as through a screen of suitable mesh.
  • Example 1 To a solution of 75 grams (containing about 120,000,000 units) of crystalline sodium penicillin G in 450 ml. of distilled water is added a solution of 75 grams of procaine hydrochlorlde in 200 ml. of distilled water. A precipitation occurs almost immediately, of the desired procaine penicillin G. The mixture then is cooled as by placing it in the ice box for about 2 hours. It is then filtered, and the procaine penicillin is washed with 500 ml. of distilled water and then with 250 ml. of acetone, and the washed material is then dried for about 12 hours under vacuum.
  • the dried procaine penicillin G is obtained in a yield of about 112 grams, with a potency of about 1000 units per mg.; or a total recovery of about 112,000,000 units, which represents a conversion and recovery penicillin of about 93% of the potency contained in the original sodium penicillin.
  • the penicillin remaining in the mother liquor may be recovered by known methods to give a material balance of substantially 100%.
  • Example 2 Example 1 is repeated save that instead of using crystalline sodium penicillin G, I use crystalline potassium penicillin G.
  • the procaine penicillin is obtained in about the same potency and in about the same yield.
  • Example 3 A penicillin-producing mold is grown in the usual way in an aqueous nutrient medium to obtain a penicillin content in the broth of about 300 units per ml.
  • the broth is separated from the mold growth by filtration, is adjusted to about pH 2 to 3, and is extracted with amyl acetate in an amount about one-fifth to onefourth the volume of the filtered broth.
  • This first amyl acetate extract is decolorized, by stirring with a small amount of decolorizing carbon for about 15 minutes, and is then separated from the carbon by filtration.
  • the decolorized first organic extract is adjusted to about pH 6.5 to '7 and extracted with a dilute aqueous sodium hydroxide solution to obtain a first aqueous extract, containing sodium penicillin in a concentration of about 10,000 to 12,000 units per m1.
  • Example 4 Three grams of dry amorphous sodium penicillin (having a potency of about 1,300 units per mg.) is dissolved in about 30 ml. of water. To this solution is added a solution of about three grams of procaine hydrochloride in ml. of water, with stirring. An almost immediate precipitation occurs, of crystalline material. The reaction mixture is placed in the refrigerator over night, and is then filtered to recover the crystalline material, which is the desired procaine penicillin. This is desirably washed, first with a small amount of water and then with a small amount of acetone, and then dried under vacuum.
  • the yield was about 2.9 grams of crystalline procaine penicillin, having a potency of about 900 units per mg., representing a conversion recovery in procaine penicillin of about 70% of the original potency of the amorphous sodium penicillin.
  • Example 5 To 1000 ml. of the decolorized first organic extract obtained as set forth in Example 3 is added with stirring about 2 grams of procaine (as the base) which for convenient handling may be dissolved in about ml. of amyl acetate. A precipitate occurs almost immediately. The stirring may be continued for about a quarter to half an hour. To insure maximum recovery, the reaction mixture is placed in the refrigerator for about two hours. The precipitate is the desired procaine penicillin, which is recovered by filtration and is desirably washed with a small amount of amyl acetate and dried under, vacuum.
  • Example 6 Ten grams of sodium penicillin G are dissolved in 1000 ml. of water and a sufficient amount (about 14 ml.) of a l-molar solution of in the procaine mixture sulfuric acid is added to obtain about pH 2. . The desirably cooled and stirred durin this add tion. The resulting mixture is extracted with 1,500 ml. of amyl acetate at a temperature of about 0 C. The amyl acetate is allowed to form a separate layer, which is recovered.
  • Example 7 Example 7-Examples 3, 4, and 6 may be repeated save that instead of using sodium penicillin, I may use potassium penicillin.
  • Example 8 Any of Examples 1 to 4 and 6 may be repeated save that instead of using sodium or potassium penicillin, I may use another inorganic salt, or an organic soluble salt of penicillin, such as the calcium salt, the ammonium salt, the N- ethyl piperidine salt, etc.
  • Example 9.Examples 5 and 6 may be repeated save that instead of using amyl acetate as the re action solvent I may use other organic solvents in which the penicillin and the procaine are soluble and in which the procaine penicillin is relatively insoluble, or I may use a mixture of organic solvents.
  • Other organic solvents which may be used are other alkyl acetates of from 4 to 9 car- I and hexyl acetate.
  • bon atoms such as butyl acetate, isoamyl acetate
  • I may also use such solvents as ether and chloroform, but with these the procaine penicillin sometimes precipitates as an oil instead of in crystalline form.
  • injectable suspensions oi procaine penicillin suitable for penicillin therapy and which give prolonged effective blood concentrations.
  • Example 10 --Crystal1ine procaine penicillin, such as that produced in Example 1 above, and having a potency of about 1,000 units per mg., and in a finely divided state (conveniently about mesh), is put up in vials each containing about 200 mg., or a potency of about 200,000 units.
  • a second vial is combined with each of such procaine-penicillin containing vials and contains about 1 ml. of distilled sterile water.
  • shortly before administration-- which may be several hours before administration-the water-containing vial is emptied into the procaine penicillin containing vial, and the mixture is shaken to produce a suspension.
  • the suspension is taken up in a hypodermic syringe, and is administered by intramuscular injection.
  • the blood concentration still remained at an effective level of 0.06 units per ml.
  • Example 11-Crystalline procaine penicillin G having a potency of about 1,000 units per mg. and in a state of fine division (conveniently about 40 mesh) is suspended in dry sterile vegetable oil, such as cottonseed oil, peanut oil, and sesame oil, in an amount suflicient to provide about 300,000 units per ml. of suspension.
  • dry sterile vegetable oil such as cottonseed oil, peanut oil, and sesame oil
  • This is packaged in suitable vials, conveniently containing about 10 ml.
  • Such vials may be packaged and shipped as such, preferably under conditions which prevent a rise of temperature above about 50 0.; and provide a unitary product ready to be injected intramuscularly to provide a supply of penicillin which is slowly absorbed and which readily maintains efi'ective penicillin blood concentrations for periods in excess of 24 hours.
  • a therapeutic composition comprising a liquid suspending medium, and finely divided solid procaine penicillin in an amount greater than will dissolve to saturate the suspending medium;
  • a therapeutic composition comprising a liquid injectable suspending medium and solid procaine penicillin having a particle size less than about 40 mesh, said procaine penicillin being present in an amount greater than will dissolve to saturate the suspending medium.
  • composition according to claim 4 in which the procaine penicillin is procaine penicillin G.
  • An injectable therapeutic composition comprising a liquid injectable suspending medium and solid procaine penicillin having a particle size less than about 40 mesh, said procaine penicillin being present in an amount greater than about 200,000 units per milliliter.
  • composition according to claim 6 in which the suspending medium is an aqueous suspending medium.
  • composition according to claim 7 in which the procaine penicillin is procaine penicillin G.
  • composition according to claim 6 in which the suspending medium is a vegetable oil.
  • composition according to claim 9 in which the procaine penicillin is procaine penicillin G.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Patented July 18, 1950 PROCAINE PENICILLIN AND THERAPEUTIC COMPOSITIONS Harley W. Rhodehamel, Jr., Indianapolis, Ind.,
assignor to Eli Lilly and Company, Indianapolis, Ind., a corporation of Indiana No Drawing. Application September 15, 1947,
Serial No. 774,183
Claims. i
This invention relates to relatively insoluble salts of penicillin, particularly procaine penicillin, to the preparation of such salts, and to compositions embodying them.
In the past, penicillin has been prepared and used in the form of its simple salts, usually the sodium or potassium salt. Such salts are highly soluble in water and in the body fluids and tend to decompose in their presence. When such salts are injected, as in water solution, the penicillin not only tends to decompose, but is rapidly taken up in the body fluids and is soon eliminated in the urine; so that the penicillin concentration in the blood remains at an effective level for but a short period of time. Because of this, when the penicillin is administered in aqueous solution, it has been necessary to give frequent injections, usually every three or four hours. Penicillin therapy requires the maintenance of effective blood concentrations over prolonged periods, usually for several days, and the necessity for frequent iniections is extremely burdensome both to the doctor and to the patient. Many attempts have been made to eliminate thenecessity for these frequent injections and to obtain some means of producing an efiective blood concentration of pencillin over a prolonged period, desirably at least 24 hours; without the necessity for such frequent injections.
One method which has been used for this purpose is by injecting the penicillin in suspension in a mixture of oil and beeswax; and while with proper concentrations and especially with suiilcient beeswax, this has been somewhat successful in producing prolonged effective concentrations of penicillin, its use is disagreeable to the patient, it may cause fibrosis, and it leaves a residual mass of beeswax which may not be absorbed by the body for several months and which in some cases requires surgical removal.
By my invention, I provide a salt of penicillin which is relatively insoluble in water and in body fluids and is non-toxic, which can be administered without discomfort to the patient and to leave no residue, and which will readily provide a supply in the body from which the penicillin will slowly absorb to maintain effective concentrations of penicillin in the blood stream over prolonged periods of time. Whereas with the known salts of penicillin maintenance of effective concentrations of penicillin requires eight or more aqueous injections per day, with my salt effective concentrations may be maintained with but a single aqueous injection a day.
I have found that procaine forms a salt with penicillin which is relatively insoluble in water 2 and in the body fluids, and that infrequent administrations of this salt, usually not oftener than once each day, will readily maintain effective concentrations of penicillin in the blood over prolonged periods.
Small quantities of procaine have previously been administered in conjunction with penicillin therapy, in part to obtain the anesthetic effect of the procaine, and in part because the procaine was found in many cases to minimize or overcome he allergy which some persons have toward peniillin. My new procaine-penicillin salt not only permits the maintenance of effective blood concentrations of penicillin over prolonged periods, but also provides the procaine for its anesthetic eifect and its anti-allergy effect.
The pencillin embodied in the'salt may be a mixture of one or more of the several specific penicillins, as obtained in the usual production of penicillin, or may be a penicillin which consists mainly or wholly of one of these specific penicillins. Preferably, I use a penicillin which is rich in penicillin G (benzyl penicillin), in part for the excellent therapeutic qualities of penicillin G but also because I find it especially useful in forming salts with desirable physical properties. The penicillin used may be either an amorphous penicillin or preferably a crystalline penicillin; and in preparing the salt, I start with either a dry penicillin or a purified solution containing the penicillin, and such solution may be One obtained directly, as by extraction, from the broth in which the penicillin is produced.
The new procaine penicillin salt may be administered in any desired way. The usually preferred way is by intra-muscular injection of a suspension of the procaine penicillin in water or other aqueous menstruum, i. e. aqueous suspending medium, or in any of the commonly used oily menstruums, i. e. oily suspending media. when it is to be administered in water suspension, the suspension is desirably a freshly prepared one, because of thetendency of the penicillin to decompose in the presence of water. For such administration, the solid procaine penicillin in an amount to provide a unit dosage, desirably about 200,000 to 300,000 international penicillin units, is put up in a sealed ampoule in combination with an ampoule of a suitable quantity of aqueous menstruum, so that the doctor may combine the two shortly before administration. In such a combination package, the procaine penicillin salt is contained in its ampoule in finely divided state, preferably less than 40' mesh size and most desirably about mesh slze. The amount of aqueous menstruum supplied in the combined vial is desirably small, but is sufficient to form a suspension of a consistency suitable for injection. With 200,000 to 300,000 units of procaine penicillin having a potency of 1,000 units per mg., I desirably use about 1 ml. of aqueous menstruum. My procaine penicillin salt lends itself to this advantageous method of administration, for it forms crystals which may be sufllciently finely divided to form the suitable suspension, and such finely divided crystalline material lends itself to convenient packaging in ampoules and when so packaged remains stable over long periods and can be distributed by usual methods and through usual channels.
To provide a composition which may be administered directly as supplied, my penicillin salt is also of advantage. line material may be suspended in any of the commonly used injectable oily menstruums, and
when so suspended in the absence of water, the
suspension may be distributed through the usual channels in the usual way and will remain stable and available for immediate use .without preliminary mixing.
My procaine-penicillin salt may be prepared by simply bringing the procaine and the penicillin together, desirably with the procaine in excess, in solution in a suitable reaction solvent. The procaine penicillin is relatively insoluble both in water and in convenient organic solvents so that it precipitates from the reaction mixture, usually quite promptly as a solid, and is conveniently recovered by filtration.
For preparation in aqueous solvent, the penicillin is conveniently and desirably added in the form of any of its usual soluble salts, such as the ammonium, potassium, sodium, or calcium salts. The procaine may likewise be present in the form of its soluble salt, such as its hydrohalide, sulfate, nitrate, formate. or the like.
The aqueous reaction mixture may be prepared in any convenient way; one of the reactants, conveniently the penicillin, may be provided in solution in sufiicient water for the reaction mixture, and the other reactant added thereto, or preferably, water solutions of each of the reactants are combined. When the penicillin and the procaine are brought together in solution in the aqueous reaction mixture, a precipitation promptly occurs,
of the desired procaine-penicillin salt. To increase recovery, the reaction mixture is desirably allowed to stand in the cold. The procaine penicillin is recovered, as b filtration, and is then preferably washed first with water and then with a low-boiling water miscible solvent, such as acetone, and then dried under vacuum.
For preparation in an organic solvent, the penicillin is desirably supplied in acid form, and the The finely divided crystalprocaine desirably in base form. As in the aqueous preparation, the two reactants and the solvent may be brought together in any desired order. When the penicillin, in acid form, and the procaine, in base form, are brought together in organic solution, they react to form the desired procaine-penicillin salt, which precipitates. The precipitate is recovered by filtration, and is desirably washed with an additional quantity of organic solvent and dried.
For preparation of the procaine penicillin in organic solution, I preferably use as the reaction solvent an alkyl acetate 01' from about 4 to 9 carbon atoms, and most desirably use amyl acetate. Other solvents, such as ether or chloroform, in which the two reactants are soluble and the procaine-penicillin is relatively insoluble, may also be used; but I find that with such other solvents the procaine-penicillin sometimes precipitates as an oil instead of in the more desirable, solid crystalline state, and that sometimes the occurrence of precipitation is delayed. In the preparation of procaine penicillin, both in water solution and in organic solvent solution, the penicillin must of course be present in a, concentration greater than the solubility of procaine penicillin in the solvent (about 0.7% in water at 28 C.), and for efllcient recoverythe penicillin should be present in a substantially higher concentration, desirably close to its maximum solubility. In addition, the penicillin used should be of fairly high purity, desirably of at least purity, for the co-presence of excessive impurities may interfere with the formation of the procaine penicillin or with its recovery in crystalline form. For example, with dry sodium or potassium penicillin G, which when pure have potencies of about 1,667 units and 1,595 units per mg. respectively, I have found it suitable to use a penicillin having a potency of about 1200 units per mg., but I prefer to use a penicillin of substantially higher potency.
With both the aqueous and the organic-solution reactions, the penicillin is desirably brought to the reaction mixture in solution, and the penicillin-containing solution may be-one which is obtained directly by extractive procedure from the broth in which the penicillin is produced. The penicillin-containing solution may for example be the first organic extract of the broth, or may be the first aqueous extract thereof, derived by extraction of that organic extract, or may be a subsequent extract, either aqueous or organic. When the penicillin is obtained in such an extract from the broth, it is desirably decolorized in organic solution before use by any suitable method.
The procaine penicillin obtained by the procedures set forth above is usually obtained in the form of crystals, although sometimes, especially when the reaction solvent is other than water or amyl acetate, the procaine penicillin may precipitate as an oil which solidifies on standing.
For use in injectable suspensions I employ crystalline procaine penicillin in finely divided state, preferably about 40 to about mesh size. The crystal size obained in the preparation of my procaine penicillin may be modified by suitably controlling the conditions under which the reaction is carried out, and crystal size is reduced by carrying out the reaction at reduced temperature and with vigorous stirring. In any event, the material if not obtained in a sufficient state of division readily lends itself to further reduction by grinding, as through a screen of suitable mesh.
The following are examples of the preparation of procaine penicillin.
Example 1.To a solution of 75 grams (containing about 120,000,000 units) of crystalline sodium penicillin G in 450 ml. of distilled water is added a solution of 75 grams of procaine hydrochlorlde in 200 ml. of distilled water. A precipitation occurs almost immediately, of the desired procaine penicillin G. The mixture then is cooled as by placing it in the ice box for about 2 hours. It is then filtered, and the procaine penicillin is washed with 500 ml. of distilled water and then with 250 ml. of acetone, and the washed material is then dried for about 12 hours under vacuum. The dried procaine penicillin G is obtained in a yield of about 112 grams, with a potency of about 1000 units per mg.; or a total recovery of about 112,000,000 units, which represents a conversion and recovery penicillin of about 93% of the potency contained in the original sodium penicillin. The penicillin remaining in the mother liquor may be recovered by known methods to give a material balance of substantially 100%.
Example 2.Example 1 is repeated save that instead of using crystalline sodium penicillin G, I use crystalline potassium penicillin G. The procaine penicillin is obtained in about the same potency and in about the same yield.
Example 3.--A penicillin-producing mold is grown in the usual way in an aqueous nutrient medium to obtain a penicillin content in the broth of about 300 units per ml. The broth is separated from the mold growth by filtration, is adjusted to about pH 2 to 3, and is extracted with amyl acetate in an amount about one-fifth to onefourth the volume of the filtered broth. This first amyl acetate extract is decolorized, by stirring with a small amount of decolorizing carbon for about 15 minutes, and is then separated from the carbon by filtration. The decolorized first organic extract is adjusted to about pH 6.5 to '7 and extracted with a dilute aqueous sodium hydroxide solution to obtain a first aqueous extract, containing sodium penicillin in a concentration of about 10,000 to 12,000 units per m1.
To 1,000 ml. of this first aqueous extract is added a solution of about six grams of procaine hydrochloride in 15 ml. of distilled water, with stirring. A precipitate occurs almost immediately, of the desired procaine penicillin. The mixture is then placed in the refrigerator for about 2 hours and is then filtered. The solid procaine penicillin so recovered is washed with about 40 m1. of distilled water and then with about 20 ml. of acetone and then dried for about 4 hours under vacuum. The dried crystalline procaine penicillin has a potency of about 900 units per mg.
Example 4.-Three grams of dry amorphous sodium penicillin (having a potency of about 1,300 units per mg.) is dissolved in about 30 ml. of water. To this solution is added a solution of about three grams of procaine hydrochloride in ml. of water, with stirring. An almost immediate precipitation occurs, of crystalline material. The reaction mixture is placed in the refrigerator over night, and is then filtered to recover the crystalline material, which is the desired procaine penicillin. This is desirably washed, first with a small amount of water and then with a small amount of acetone, and then dried under vacuum. In a preparation according to this example, the yield was about 2.9 grams of crystalline procaine penicillin, having a potency of about 900 units per mg., representing a conversion recovery in procaine penicillin of about 70% of the original potency of the amorphous sodium penicillin.
Example 5.-To 1000 ml. of the decolorized first organic extract obtained as set forth in Example 3 is added with stirring about 2 grams of procaine (as the base) which for convenient handling may be dissolved in about ml. of amyl acetate. A precipitate occurs almost immediately. The stirring may be continued for about a quarter to half an hour. To insure maximum recovery, the reaction mixture is placed in the refrigerator for about two hours. The precipitate is the desired procaine penicillin, which is recovered by filtration and is desirably washed with a small amount of amyl acetate and dried under, vacuum.
Example 6.Ten grams of sodium penicillin G are dissolved in 1000 ml. of water and a sufficient amount (about 14 ml.) of a l-molar solution of in the procaine mixture sulfuric acid is added to obtain about pH 2. .The desirably cooled and stirred durin this add tion. The resulting mixture is extracted with 1,500 ml. of amyl acetate at a temperature of about 0 C. The amyl acetate is allowed to form a separate layer, which is recovered.
To this amyl acetate solution, which contains the penicillin, are added about 10 grams of procaine (as the base), conveniently in solution in about ml. of amyl acetate, and the mixture is stirred for about half an hour. A precipitate occurs almost immediately, and to insure complete recovery the reaction mixture is cooled in the refrigerator for about two hours. The precipitate is the desired procaine penicillin, which is recovered by filtration and is desirably washed with amyl acetate and dried.
Example 7.-Examples 3, 4, and 6 may be repeated save that instead of using sodium penicillin, I may use potassium penicillin.
Example 8.Any of Examples 1 to 4 and 6 may be repeated save that instead of using sodium or potassium penicillin, I may use another inorganic salt, or an organic soluble salt of penicillin, such as the calcium salt, the ammonium salt, the N- ethyl piperidine salt, etc.
Example 9.Examples 5 and 6 may be repeated save that instead of using amyl acetate as the re action solvent I may use other organic solvents in which the penicillin and the procaine are soluble and in which the procaine penicillin is relatively insoluble, or I may use a mixture of organic solvents. Other organic solvents which may be used are other alkyl acetates of from 4 to 9 car- I and hexyl acetate.
bon atoms, such as butyl acetate, isoamyl acetate, I may also use such solvents as ether and chloroform, but with these the procaine penicillin sometimes precipitates as an oil instead of in crystalline form.
The following are examples of injectable suspensions oi procaine penicillin suitable for penicillin therapy and which give prolonged effective blood concentrations.
Example 10.--Crystal1ine procaine penicillin, such as that produced in Example 1 above, and having a potency of about 1,000 units per mg., and in a finely divided state (conveniently about mesh), is put up in vials each containing about 200 mg., or a potency of about 200,000 units. A second vial is combined with each of such procaine-penicillin containing vials and contains about 1 ml. of distilled sterile water. Shortly before administration--which may be several hours before administration-the water-containing vial is emptied into the procaine penicillin containing vial, and the mixture is shaken to produce a suspension. The suspension is taken up in a hypodermic syringe, and is administered by intramuscular injection.
In a typical case. in a patient receiving an intramuscular injection of an aqueous procainepenicillin suspension prepared as set forth in this example and containing only 200,000 units of penicillin activity, blood levels of penicillin concentration were maintained as follows:
At the end of the 24 hour test period, the blood concentration still remained at an effective level of 0.06 units per ml.
Example 11.-Crystalline procaine penicillin G, having a potency of about 1,000 units per mg. and in a state of fine division (conveniently about 40 mesh) is suspended in dry sterile vegetable oil, such as cottonseed oil, peanut oil, and sesame oil, in an amount suflicient to provide about 300,000 units per ml. of suspension. This is packaged in suitable vials, conveniently containing about 10 ml. Such vials may be packaged and shipped as such, preferably under conditions which prevent a rise of temperature above about 50 0.; and provide a unitary product ready to be injected intramuscularly to provide a supply of penicillin which is slowly absorbed and which readily maintains efi'ective penicillin blood concentrations for periods in excess of 24 hours.
In a typical case, in a patient receiving an intramuscular injection of one ml. of a suspension of crystalline procaine-penicillin in cottonseed oil, with the suspension containing about 300,000 units of penicillin per ml., and with the procaine penicillin in about 40-mesh size, blood levels of penicillin were maintained as follows:
Penicillin blood-concentration f i gg f' Hours 0.406 unit per ml 1 0.248 unit per ml 0.124 unit per ml 0.124 unit per m1 Example 12.Instead of the simple water or oily menstruums of Examples 10 and 1'. I may use mixed menstruums, or menstruums which themselves tend to prolong the effective blood concentrations of penicillin. One such men- .cottonseed oil, with procaine penicillin G present in an amount to give about 300,000 units per ml.;
and the emulsionyvas stabilized with about 0.04%
of a water-soluble emulsifying agent and about 0.04% of an oil-soluble emulsifying agent, and
025% phenol was added as a preservative. In a typical case, in a patient receiving 1 m1. of this suspension, blood levels of penicillin were maintained as follows:
I claim as my invention:
1. A solid procaine salt of penicillin.
2. A solid procaine salt of penicillin G.
3. A therapeutic composition comprising a liquid suspending medium, and finely divided solid procaine penicillin in an amount greater than will dissolve to saturate the suspending medium;
4. A therapeutic composition comprising a liquid injectable suspending medium and solid procaine penicillin having a particle size less than about 40 mesh, said procaine penicillin being present in an amount greater than will dissolve to saturate the suspending medium.
5. A composition according to claim 4 in which the procaine penicillin is procaine penicillin G.
6. An injectable therapeutic composition comprising a liquid injectable suspending medium and solid procaine penicillin having a particle size less than about 40 mesh, said procaine penicillin being present in an amount greater than about 200,000 units per milliliter.
7. A composition according to claim 6 in which the suspending medium is an aqueous suspending medium.
8. A composition according to claim 7 in which the procaine penicillin is procaine penicillin G.
9. A composition according to claim 6 in which the suspending medium is a vegetable oil.
10. A composition according to claim 9 in which the procaine penicillin is procaine penicillin G.
HARLEY W. RHODEHAMEL, JR.
REFERENCES CITED The following references are of record in the file of this patent:
Proc. Soc. Exptl. Biol. and Med., June. 1942, pp. 285 to 288.
Science, Sept. 1, 1944, pp. 196 to 198.
Science, Nov. 3, 1944, pp. 412 and 413.
Lancet, Nov. 11, 1944, g. 623-167-65P.
Proceeding of Staff Meeting of Mayo Clinic, Feb. 7. 1945, pp. 40, 41.
Journal American Med. Assoc, July 21, 1945. p. 910.
British Reports 234, pp. 1-5, Feb. 12, 1946.
J. Amer. Phar. Assoc. Pract. Pharm. Ed., Am 1946, p. 363.

Claims (2)

1. A SOLID PROCAINE SALT OF PENICILLIN.
3. A THERAPEUTIC COMPOSITION COMPRISING A LIQUID SUSPENDING MEDIUM, AND FINELY DIVIDED SOLID PROCAINE PENICILLIN IN AN AMOUNT GREATER THAN WILL DISSOLVE TO SATURATE THE SUSPENDING MEDIUM.
US774183A 1947-09-15 1947-09-15 Procaine penicillin and therapeutic compositions Expired - Lifetime US2515898A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US774183A US2515898A (en) 1947-09-15 1947-09-15 Procaine penicillin and therapeutic compositions
GB3193/48A GB651412A (en) 1947-09-15 1948-02-03 Improvements in or relating to process of preparing procaine penicillin and the product resulting therefrom
AU18762/48A AU141817B2 (en) 1947-09-15 1948-02-26 Improvements in or relating to slow acting solid procaine penicillin salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US774183A US2515898A (en) 1947-09-15 1947-09-15 Procaine penicillin and therapeutic compositions

Publications (1)

Publication Number Publication Date
US2515898A true US2515898A (en) 1950-07-18

Family

ID=25100484

Family Applications (1)

Application Number Title Priority Date Filing Date
US774183A Expired - Lifetime US2515898A (en) 1947-09-15 1947-09-15 Procaine penicillin and therapeutic compositions

Country Status (3)

Country Link
US (1) US2515898A (en)
AU (1) AU141817B2 (en)
GB (1) GB651412A (en)

Cited By (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2578651A (en) * 1948-10-19 1951-12-18 Bristol Lab Inc 1, 1, diphenyl-3(n-piperidyl) propane salts of penicillin
US2585432A (en) * 1948-10-19 1952-02-12 Bristol Lab Inc Dibenzylamine salts of penicillin
US2619447A (en) * 1949-03-11 1952-11-25 American Cyanamid Co Injectable penicillin preparations
US2643251A (en) * 1950-03-29 1953-06-23 Bristol Lab Inc Precipitation of fine particle procaine penicillin g
US2650217A (en) * 1950-08-24 1953-08-25 Merck & Co Inc Production of quinine-penicillin
US2654743A (en) * 1952-02-13 1953-10-06 Lilly Co Eli Delta-piperidinobutyl diphenylacetate salt of penicillin
US2654752A (en) * 1952-02-13 1953-10-06 Lilly Co Eli Beta-4-morpholinoethyl-benzoate salt of penicillin
US2654751A (en) * 1952-02-13 1953-10-06 Lilly Co Eli Substituted 2-methylipiperidinopropyl benzoate salts of penicillin
US2654742A (en) * 1952-02-13 1953-10-06 Lilly Co Eli Gamma-morpholinopropyl cinnamate salt of penicillin
US2654749A (en) * 1952-02-13 1953-10-06 Lilly Co Eli Salts of penicillin with dimethylamino, diphenyl-substituted esters
US2654750A (en) * 1952-02-13 1953-10-06 Lilly Co Eli Penicillin salt of an amine
US2659722A (en) * 1949-04-09 1953-11-17 Leo Pharm Prod Ltd Penicillin salts of aminoalkylhydroxybenzoates
US2666760A (en) * 1951-07-06 1954-01-19 American Cyanamid Co Insoluble methyl-benzodiazepin salts of penicillin
US2668812A (en) * 1951-01-16 1954-02-09 American Cyanamid Co Penicillin salt of n, n'-bis-p, p'-carbodiethylaminoethoxyphenyl urea
US2676173A (en) * 1951-02-20 1954-04-20 Schenley Ind Inc Penicillin salts of oxybenzylisobutyl amines
US2678313A (en) * 1954-05-11 Stable molecular compounds of
US2683711A (en) * 1950-02-07 1954-07-13 Boots Pure Drug Co Ltd Penicillin-amine salts
US2694665A (en) * 1949-08-03 1954-11-16 Upjohn Co Procaine-penicillin g composition
US2701796A (en) * 1950-11-16 1955-02-08 Rheinpreussen Ag Penicillin salts of amino salicylates
US2710863A (en) * 1951-01-09 1955-06-14 Chimiotherapie Lab Franc Penicillin benzhydryl-amine salt
US2712010A (en) * 1951-04-04 1955-06-28 American Home Prod Preparation of habit-modified procaine penicillin
US2712009A (en) * 1951-04-04 1955-06-28 American Home Prod Preparation of habit-modified procaine penicillin
US2715090A (en) * 1949-05-25 1955-08-09 Lab Francais Chimiotherapie Organic penicillin salt solutions having a delayed action and process for making same
US2721198A (en) * 1953-08-27 1955-10-18 Bristol Lab Inc Amine salts of penicillin
US2725336A (en) * 1950-11-06 1955-11-29 Pfizer & Co C Preparation containing modified procaine penicillin crystals and process for preparing such crystals
US2727892A (en) * 1952-07-10 1955-12-20 Pfizer & Co C Preparation of procaine penicillin
US2728764A (en) * 1952-08-15 1955-12-27 Bristol Lab Inc Penicillin salts of n-benzhydryl-diisopropylamine
US2728705A (en) * 1951-08-21 1955-12-27 Lilly Co Eli Sterile penicillin compositions and their preparation
US2739098A (en) * 1950-03-31 1956-03-20 Merck & Co Inc Procaine penicillin
US2739962A (en) * 1953-10-29 1956-03-27 Commercial Solvents Corp Production of crystalline procaine penicillin
US2741573A (en) * 1953-12-28 1956-04-10 Abbott Lab Penicillin compositions for intramuscular injection
US2743268A (en) * 1952-07-12 1956-04-24 Lilly Co Eli Erythromycin-penicillin
US2749274A (en) * 1952-05-06 1956-06-05 Bristol Lab Inc Stable aqueous procaine penicillin suspension
DE955060C (en) * 1951-02-17 1956-12-27 Biochemie Gmbh Process for the preparation of penicillin salts
DE1005967B (en) * 1952-03-03 1957-04-11 American Home Prod Process for the production of poorly soluble penicillin salts
DE962794C (en) * 1951-03-13 1957-04-25 Biochemie Gmbh Process for the production of pure, crystallized, poorly water-soluble penicillin salts of organic bases
US2793156A (en) * 1950-08-17 1957-05-21 Bristol Lab Inc Repository penicillin products
US2830932A (en) * 1952-12-06 1958-04-15 Abbott Lab N,n'dibenzylethylene diamine salt of heparin
US3022290A (en) * 1957-12-06 1962-02-20 Olin Mathieson Procaine penicillin production
US3096249A (en) * 1960-05-10 1963-07-02 Samuel J Prigal Emulsion composition
US3170836A (en) * 1962-05-24 1965-02-23 Glaxo Lab Ltd Injectable compositions comprising a copper-containing chelate complex compound dispersed in a stabilized oil-in-water emulsion and method of using the same
WO2004058223A1 (en) 2002-12-20 2004-07-15 St. James Associates Llc/Faber Research Series Coated particles for sustained-release pharmaceutical administration
US20050043288A1 (en) * 2003-08-21 2005-02-24 Thomas Tobin Composition and method for marking procaine penicillin
US20060058280A1 (en) * 2004-08-11 2006-03-16 Kal Reddy A Preparation of penicillin procaine
US20070218139A1 (en) * 2002-12-20 2007-09-20 Smith Thomas J High Pressure Compaction For Pharmaceutical Formulations
US9987233B2 (en) 2013-03-21 2018-06-05 Eupraxia Pharmaceuticals USA LLC Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
US11351124B2 (en) 2015-10-27 2022-06-07 Eupraxia Pharmaceuticals Inc. Sustained release of formulations of local anesthetics

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2678313A (en) * 1954-05-11 Stable molecular compounds of
US2578651A (en) * 1948-10-19 1951-12-18 Bristol Lab Inc 1, 1, diphenyl-3(n-piperidyl) propane salts of penicillin
US2585432A (en) * 1948-10-19 1952-02-12 Bristol Lab Inc Dibenzylamine salts of penicillin
US2619447A (en) * 1949-03-11 1952-11-25 American Cyanamid Co Injectable penicillin preparations
US2659722A (en) * 1949-04-09 1953-11-17 Leo Pharm Prod Ltd Penicillin salts of aminoalkylhydroxybenzoates
US2715090A (en) * 1949-05-25 1955-08-09 Lab Francais Chimiotherapie Organic penicillin salt solutions having a delayed action and process for making same
US2694665A (en) * 1949-08-03 1954-11-16 Upjohn Co Procaine-penicillin g composition
US2683711A (en) * 1950-02-07 1954-07-13 Boots Pure Drug Co Ltd Penicillin-amine salts
US2643251A (en) * 1950-03-29 1953-06-23 Bristol Lab Inc Precipitation of fine particle procaine penicillin g
US2739098A (en) * 1950-03-31 1956-03-20 Merck & Co Inc Procaine penicillin
US2793156A (en) * 1950-08-17 1957-05-21 Bristol Lab Inc Repository penicillin products
US2650217A (en) * 1950-08-24 1953-08-25 Merck & Co Inc Production of quinine-penicillin
US2725336A (en) * 1950-11-06 1955-11-29 Pfizer & Co C Preparation containing modified procaine penicillin crystals and process for preparing such crystals
US2701796A (en) * 1950-11-16 1955-02-08 Rheinpreussen Ag Penicillin salts of amino salicylates
US2710863A (en) * 1951-01-09 1955-06-14 Chimiotherapie Lab Franc Penicillin benzhydryl-amine salt
US2668812A (en) * 1951-01-16 1954-02-09 American Cyanamid Co Penicillin salt of n, n'-bis-p, p'-carbodiethylaminoethoxyphenyl urea
DE955060C (en) * 1951-02-17 1956-12-27 Biochemie Gmbh Process for the preparation of penicillin salts
US2676173A (en) * 1951-02-20 1954-04-20 Schenley Ind Inc Penicillin salts of oxybenzylisobutyl amines
DE962794C (en) * 1951-03-13 1957-04-25 Biochemie Gmbh Process for the production of pure, crystallized, poorly water-soluble penicillin salts of organic bases
US2712009A (en) * 1951-04-04 1955-06-28 American Home Prod Preparation of habit-modified procaine penicillin
US2712010A (en) * 1951-04-04 1955-06-28 American Home Prod Preparation of habit-modified procaine penicillin
US2666760A (en) * 1951-07-06 1954-01-19 American Cyanamid Co Insoluble methyl-benzodiazepin salts of penicillin
US2728705A (en) * 1951-08-21 1955-12-27 Lilly Co Eli Sterile penicillin compositions and their preparation
US2654750A (en) * 1952-02-13 1953-10-06 Lilly Co Eli Penicillin salt of an amine
US2654749A (en) * 1952-02-13 1953-10-06 Lilly Co Eli Salts of penicillin with dimethylamino, diphenyl-substituted esters
US2654742A (en) * 1952-02-13 1953-10-06 Lilly Co Eli Gamma-morpholinopropyl cinnamate salt of penicillin
US2654751A (en) * 1952-02-13 1953-10-06 Lilly Co Eli Substituted 2-methylipiperidinopropyl benzoate salts of penicillin
US2654752A (en) * 1952-02-13 1953-10-06 Lilly Co Eli Beta-4-morpholinoethyl-benzoate salt of penicillin
US2654743A (en) * 1952-02-13 1953-10-06 Lilly Co Eli Delta-piperidinobutyl diphenylacetate salt of penicillin
DE1005967B (en) * 1952-03-03 1957-04-11 American Home Prod Process for the production of poorly soluble penicillin salts
US2749274A (en) * 1952-05-06 1956-06-05 Bristol Lab Inc Stable aqueous procaine penicillin suspension
US2727892A (en) * 1952-07-10 1955-12-20 Pfizer & Co C Preparation of procaine penicillin
US2743268A (en) * 1952-07-12 1956-04-24 Lilly Co Eli Erythromycin-penicillin
US2728764A (en) * 1952-08-15 1955-12-27 Bristol Lab Inc Penicillin salts of n-benzhydryl-diisopropylamine
US2830932A (en) * 1952-12-06 1958-04-15 Abbott Lab N,n'dibenzylethylene diamine salt of heparin
US2721198A (en) * 1953-08-27 1955-10-18 Bristol Lab Inc Amine salts of penicillin
US2739962A (en) * 1953-10-29 1956-03-27 Commercial Solvents Corp Production of crystalline procaine penicillin
US2741573A (en) * 1953-12-28 1956-04-10 Abbott Lab Penicillin compositions for intramuscular injection
US3022290A (en) * 1957-12-06 1962-02-20 Olin Mathieson Procaine penicillin production
US3096249A (en) * 1960-05-10 1963-07-02 Samuel J Prigal Emulsion composition
US3170836A (en) * 1962-05-24 1965-02-23 Glaxo Lab Ltd Injectable compositions comprising a copper-containing chelate complex compound dispersed in a stabilized oil-in-water emulsion and method of using the same
US20070218139A1 (en) * 2002-12-20 2007-09-20 Smith Thomas J High Pressure Compaction For Pharmaceutical Formulations
WO2004058223A1 (en) 2002-12-20 2004-07-15 St. James Associates Llc/Faber Research Series Coated particles for sustained-release pharmaceutical administration
US9492388B2 (en) 2002-12-20 2016-11-15 St. James Associates Llc/Faber Research Series Coated particles for sustained-release pharmaceutical administration
US20050043288A1 (en) * 2003-08-21 2005-02-24 Thomas Tobin Composition and method for marking procaine penicillin
WO2005020840A3 (en) * 2003-08-21 2005-06-16 Thomas Tobin Composition and method for marking procaine penicillin
WO2005020840A2 (en) * 2003-08-21 2005-03-10 Thomas Tobin Composition and method for marking procaine penicillin
US20060058280A1 (en) * 2004-08-11 2006-03-16 Kal Reddy A Preparation of penicillin procaine
US7446194B2 (en) 2004-08-11 2008-11-04 Cross Vetpharm Limited Preparation of penicillin procaine
US9987233B2 (en) 2013-03-21 2018-06-05 Eupraxia Pharmaceuticals USA LLC Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
US11219604B2 (en) 2013-03-21 2022-01-11 Eupraxia Pharmaceuticals USA LLC Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
US11351124B2 (en) 2015-10-27 2022-06-07 Eupraxia Pharmaceuticals Inc. Sustained release of formulations of local anesthetics

Also Published As

Publication number Publication date
GB651412A (en) 1951-04-04
AU1876248A (en) 1948-04-29
AU141817B2 (en) 1951-06-26

Similar Documents

Publication Publication Date Title
US2515898A (en) Procaine penicillin and therapeutic compositions
US3004894A (en) Therapeutic composition comprising tetracycline and a dioxolane
US3089815A (en) Injectable pharmaceutical preparation, and a method of making same
EP0297580A1 (en) Amorphous form of aztreonam
EP0189941B1 (en) Antibiotic compositions
US4861786A (en) Composition for a stable vein compatible injectable solution of torasemide process for the preparation and method of use
US3966962A (en) Triacetin solutions of PGE-type compounds
US4696814A (en) Parenteral phenytoin compositions
CS214798B2 (en) Method of stabilization of active substances
US4235900A (en) Cephradine compositions
US4631292A (en) 1,3-dioxane derivatives, method of their synthesis and anti-peptic ulcer agent
JPS62149621A (en) Drug containing phosphonucreatine and manufacture
US4389414A (en) Prostaglandin compositions
US2650217A (en) Production of quinine-penicillin
JPH0246592B2 (en)
EP0278243B1 (en) Medical preparation comprising aspoxicillin, a method for its preparation, and the use of such a preparation for the manufacture of a medicament
US2910403A (en) Anti hypertensive compositions comprising 2-methyl-5, 8-dimethoxychromone and acetamides
EP0029668B1 (en) Pharmaceutical injectable composition and two-pack container for said composition
US2830932A (en) N,n'dibenzylethylene diamine salt of heparin
US2715090A (en) Organic penicillin salt solutions having a delayed action and process for making same
US4222939A (en) Process for preparing solid sodium amoxycillin
US5420124A (en) Stable, painless piroxicam potassium injectable composition
US3025311A (en) Hydrocortisone 21-beta beta-dimethyl glutarate and derivatives thereof
US4088759A (en) Injectable pharmaceutical solutions
US2676961A (en) Procaine-penicillin preparation